| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $658K | -14.3% |
| Cost of Revenue | $104K | -71.5% |
| Gross Profit | $554K | +37.5% |
| R&D Expense | $21.7M | -4.6% |
| SG&A Expense | $11.8M | +52.6% |
| Operating Income | -$32.9M | -9.5% |
| Interest Expense | $85K | +93.2% |
| Net Income | -$32.3M | -8.0% |
| EPS (Basic) | $0.42 | -6.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.7M | -19.7% |
| Accounts Receivable | $185K | +0.0% |
| Current Assets | $22.1M | -59.6% |
| Total Assets | $29.7M | -54.1% |
| Current Liabilities | $6.7M | -32.2% |
| Total Liabilities | $7.2M | -42.3% |
| Stockholders' Equity | $22.5M | -55.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.6M | -26.5% |
| Capital Expenditures | $812K | -44.6% |
| Investing Cash Flow | $27.3M | +276.2% |
| Financing Cash Flow | $22K | -100.0% |
| Free Cash Flow | -$32.4M | -22.5% |